Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Sharon Tetlow; Deborah Neff; Ruben Mesa

Premium

Pathwork Diagnostics has hired Sharon Tetlow to be its new chief financial officer. Tetlow previously served as vice president and CFO at Cell Genesys and she was a venture partner at Apax Partners.


Bio-Rad Laboratories has appointed Deborah Neff to its board of directors, the company said in a recent filing with the US Securities and Exchange Commission.

Neff has been president and CEO of Pathwork Diagnostics since 2006. From 2003 to 2006, she was CEO of Predicant Biosciences and from 1988 to 2003, she held management positions at BD Biosciences, a business unit of Becton Dickinson, where she was worldwide president from 1995 until 2003.


23andMe has named Ruben Mesa to serve on its Myeloproliferative Neoplasms research project advisory board. Mesa has been a professor at Mayo Clinic since 2002, where he currently is chair of the Division of Hematology and Medical Oncology.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.